Johnson & Johnson has secured authorisation for its Covid-19 vaccine under interim order (IO) from Health Canada for emergency use. Developed by the Janssen Pharmaceutical Companies of Johnson
The post Johnson & Johnson’s Covid-19 vaccine receives interim order authorisation in Canada appeared first on Pharmaceutical Business review.
This is not a CAPTIS article. Originally, it was published here.